subscribeSubscribe
Genentech tries again on diversity aim for Alzheimer`s program

Genentech tries again on diversity aim for Alzheimer`s program
Annalee Armstrong FIERCEBIOTECH
08 Aug 2022
Share Share
Genentech, AC Immune reveal more about crenezumab failure

Genentech, AC Immune reveal more about crenezumab failure
Annalee Armstrong FIERCEBIOTECH
02 Aug 2022
Share Share
NextGen: Alzheimer`s therapy developers find reason for optimism

NextGen: Alzheimer`s therapy developers find reason for optimism
Annalee Armstrong FIERCEBIOTECH
29 Jun 2022
Share Share
Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial

Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial
Phil Taylor PHARMAPHORUM
17 Jun 2022
Share Share
AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab

AC Immune Provides Update On Alzheimer’s Prevention Initiative Study Evaluating Crenezumab
PRESS RELEASE
16 Jun 2022
Share Share
Shehnaaz Suliman dives back into Alzheimer`s at Alector

Shehnaaz Suliman dives back into Alzheimer`s at Alector
Kathy Wong ENDPTS
14 Dec 2019
Share Share
Investors lost big as Alzheimer’s R&D went over the cliff in 2019

Investors lost big as Alzheimer’s R&D went over the cliff in 2019
John Carroll ENDPOINTS NEWS
11 Sep 2019
Share Share
Pharma companies clear the R&D decks in Q4

Pharma companies clear the R&D decks in Q4
Phil Taylor PHARMAPHORUM
11 Feb 2019
Share Share
Is Biogen’s Aducanumab for Alzheimer’s the Holy Grail or Cold Fusion?

Is Biogen’s Aducanumab for Alzheimer’s the Holy Grail or Cold Fusion?
Mark Terry BIOSPACE
03 Feb 2019
Share Share
Roche, AC Immune drop Alzheimer drug trials after setback

Roche, AC Immune drop Alzheimer drug trials after setback
John Miller REUTERS
31 Jan 2019
Share Share